Related Experiment Videos

Anticardiolipin antibody and stroke: possible relation of valvular heart disease and embolic events

D Barbut1, J S Borer, D Wallerson

  • 1Department of Neurology, New York Hospital-Cornell Medical Center, N.Y.

Cardiology
|January 1, 1991
PubMed

Insights

Strokes in anticardiolipin antibody (Acla) syndrome are often embolic from the heart. Valvular heart disease, common in Acla patients, is linked to these cardioembolic strokes.

Area of Science:

  • Cardiology
  • Neurology
  • Rheumatology

Background:

  • Anticardiolipin antibody (Acla) syndrome is associated with an increased risk of thrombotic events, including stroke.
  • The specific etiology and cardiac involvement in Acla-related strokes require further elucidation.

Purpose of the Study:

  • To determine the cause of strokes in patients with Acla syndrome.
  • To investigate the relationship between valvular heart disease and stroke in the context of Acla.

Main Methods:

  • Retrospective analysis of clinical and objective data from 21 patients with Acla and focal cerebral ischemic events.
  • Echocardiographic assessment for valvular abnormalities.

Main Results:

  • Left-sided valvular abnormalities were found in 86% of stroke patients versus 42% of non-stroke patients.
  • Cardioembolic stroke features were present in 86% of patients experiencing stroke.

Conclusions:

  • Strokes in Acla syndrome are predominantly cardioembolic.
  • Valvular heart disease is a significant risk factor for stroke in Acla syndrome, suggesting a cardiac source for emboli.

Related Concept Videos